Prati
David Hufnagel
David Hufnagel
Senior Scientist
Nema potvrđene e-adrese
Naslov
Citirano
Citirano
Godina
Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection
VI Band, DA Hufnagel, S Jaggavarapu, EX Sherman, JE Wozniak, ...
Nature microbiology 4 (10), 1627-1635, 2019
1242019
Disease to dirt: the biology of microbial amyloids
DA Hufnagel, Ç Tükel, MR Chapman
PLoS pathogens 9 (11), e1003740, 2013
1172013
Iron induces bimodal population development by Escherichia coli
WH DePas, DA Hufnagel, JS Lee, LP Blanco, HC Bernstein, ST Fisher, ...
Proceedings of the National Academy of Sciences 110 (7), 2629-2634, 2013
1162013
The Biology of the Escherichia coli Extracellular Matrixs
DA Hufnagel, WH Depas, MR Chapman
Microbial biofilms, 249-267, 2015
1092015
Experimental manipulation of the microbial functional amyloid called curli
Y Zhou, DR Smith, DA Hufnagel, MR Chapman
Bacterial cell surfaces: Methods and protocols, 53-75, 2013
1012013
Modulation of curli assembly and pellicle biofilm formation by chemical and protein chaperones
EK Andersson, C Bengtsson, ML Evans, E Chorell, M Sellstedt, ...
Chemistry & biology 20 (10), 1245-1254, 2013
732013
The Catabolite Repressor Protein-Cyclic AMP Complex Regulates csgD and Biofilm Formation in Uropathogenic Escherichia coli
DA Hufnagel, ML Evans, SE Greene, JS Pinkner, SJ Hultgren, ...
Journal of bacteriology 198 (24), 3329-3334, 2016
622016
The disulfide bonding system suppresses CsgD-independent cellulose production in Escherichia coli
DA Hufnagel, WH DePas, MR Chapman
Journal of bacteriology 196 (21), 3690-3699, 2014
372014
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
VI Band, SW Satola, RD Smith, DA Hufnagel, C Bower, AB Conley, ...
MBio 12 (1), 10.1128/mbio. 02881-20, 2021
35*2021
MCR-1 confers cross-resistance to lysozyme
EX Sherman, DA Hufnagel, DS Weiss
The Lancet Infectious Diseases 16 (11), 1226-1227, 2016
192016
Thiol starvation induces redox-mediated dysregulation of Escherichia coli biofilm components
DA Hufnagel, JE Price, RE Stephenson, J Kelley, MF Benoit, ...
Journal of Bacteriology 200 (1), 10.1128/jb. 00389-17, 2018
172018
1, 3-Dioxane-linked novel bacterial topoisomerase inhibitors: expanding structural diversity and the antibacterial spectrum
Y Lu, CA Mann, S Nolan, JA Collins, E Parker, J Papa, S Vibhute, ...
ACS Medicinal Chemistry Letters 13 (6), 955-963, 2022
32022
Antibiotic-selected gene amplification heightens metal resistance
DA Hufnagel, JE Choby, S Hao, AF Johnson, EM Burd, C Langelier, ...
Mbio 12 (1), 10.1128/mbio. 02994-20, 2021
32021
Pre-existing heterogeneity facilitates development of heteroresistance upon gene acquisition
S Jaggavarapu, DA Hufnagel, DS Weiss
bioRxiv, 2023
22023
Environmental and Molecular Control of the Uropathogenic Escherichia coli Extracellular Matrix.
DAE Hufnagel
12016
Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages
S Jahanbakhsh, J Howland, MO Ndayishimiye Uwineza, MT Thwaites, ...
JAC-Antimicrobial Resistance 5 (5), dlad104, 2023
2023
Evaluation of Dilution Susceptibility Testing Methods for Aztreonam in Combination with Avibactam against Enterobacterales
CJ Kelley, A Kennedy-Mendez, ON Walser, MT Thwaites, FF Arhin, ...
Microbiology Spectrum 10 (6), e03601-22, 2022
2022
501 Investigating the activity of pravibismane against bacterial isolates common in cystic fibrosis pulmonary infections
B Baker, S Hawser, N Kothari, T Valmont, C Pillar, D Hufnagel, A Mendez, ...
Journal of Cystic Fibrosis 21, S283, 2022
2022
Systems and Methods for Determining Antimicrobial Resistance of a Sample Using Surface Topography Determined from Optical Imaging Data
D Weiss, D Hufnagel, P Yunker, A Kalziqi
US Patent App. 17/625,713, 2022
2022
Multiple Heteroresistance to Guide Combination Antibiotic Regimens
D Weiss, V Band, D Hufnagel
US Patent App. 17/277,857, 2021
2021
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20